United States · FDA National Drug Code directory
Olanzapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71209-076_a7f753c2-1d2b-4b4f-b0e5-250bf951e7c6
- Product NDC
- 71209-076
- Form
- TABLET
- Composition / generic term
- Olanzapine
- Labeler
- Cadila Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190213
- Source listing expiry
- 20261231
Source-listed ingredients
- OLANZAPINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71209-076-01) · 71209-076-01
- 100 TABLET in 1 BOTTLE (71209-076-05) · 71209-076-05
- 500 TABLET in 1 BOTTLE (71209-076-10) · 71209-076-10
- 1000 TABLET in 1 BOTTLE (71209-076-11) · 71209-076-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →